Evidence map›Paper›PMID 40184562›Full record

ArticlePLoS computational biology2025

Why the growth of arboviral diseases necessitates a new generation of global risk maps and future projections.

Oliver J Brady, Leonardo S Bastos, Jamie M Caldwell, Simon Cauchemez, Hannah E Clapham, Illaria Dorigatti, Katy A M Gaythorpe, Wenbiao Hu, Laith Hussain-Alkhateeb, Michael A Johansson and 13 more

Abstract read
In one paragraph

Article in PLoS computational biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. A Review of the Changing Global Impact of Arthropod-Borne Virus Diseases and Recent Initiatives from the World Health Organization.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Review
  4. Zika Virus: A Tale of Two Lineages.Pathogens (Basel, Switzerland) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Oliver J BradyDepartment of Infectious Disease Epidemiology and Dynamics, London School of Hygiene and Tropical Medicine, London, United Kingdom.ORCID 0000-0002-3235-2129
Leonardo S BastosScientific Computing Programme, Oswaldo Cruz Foundation: Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil.
Jamie M CaldwellHigh Meadows Environmental Institute, Princeton University, Princeton, New Jersey, United States of America.
Simon CauchemezMathematical Modelling of Infectious Diseases Unit, Institut Pasteur, Université Paris Cité, UMR2000 CNRS, Paris, France.
Hannah E ClaphamSaw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.
Illaria DorigattiMedical Research Council Centre for Global Infectious Disease Analysis, Imperial College London, London, United Kingdom.
Katy A M GaythorpeMedical Research Council Centre for Global Infectious Disease Analysis, Imperial College London, London, United Kingdom.
Wenbiao HuSchool of Public Health and Social Work, Queensland University of Technology, Brisbane, Australia.
Laith Hussain-AlkhateebGlobal Health Research Group, School of Public Health and Community Medicine, University of Gothenburg: Goteborgs Universitet, Gothenburg, Sweden.
Michael A JohanssonDengue Branch, Centers for Disease Control and Prevention, San Juan, Puerto Rico, United States of America.
Ahyoung LimDepartment of Infectious Disease Epidemiology and Dynamics, London School of Hygiene and Tropical Medicine, London, United Kingdom.ORCID 0000-0003-4445-5034
Velma K LopezDengue Branch, Centers for Disease Control and Prevention, San Juan, Puerto Rico, United States of America.
Richard James MaudeMahidol Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand.ORCID 0000-0002-5355-0562
Jane P MessinaSchool of Geography and the Environment, University of Oxford, Oxford, United Kingdom.
Erin A MordecaiBiology Department, Stanford University, Stanford, California, United States of America.
Andrew Townsend PetersonBiodiversity Institute, The University of Kansas Biodiversity Institute and Natural History Museum, Lawrence, Kansas, United States of America.ORCID 0000-0003-0243-2379
Isabel Rodriquez-BarraquerDepartment of Medicine, University of California San Francisco, San Francisco, California, United States of America.
Ingrid B RabeDepartment of Epidemic and Pandemic Preparedness and Prevention, World Health Organization, Geneva, Switzerland.
Diana P RojasDepartment of Epidemic and Pandemic Preparedness and Prevention, World Health Organization, Geneva, Switzerland.
Sadie J RyanDepartment of Geography and the Emerging Pathogens Institute, University of Florida, Gainesville, Florida, United States of America.ORCID 0000-0002-4308-6321
Henrik SaljeDepartment of Genetics, University of Cambridge, Cambridge, United Kingdom.
Jan C SemenzaHeidelberg Institute of Global Health, University of Heidelberg: Universitat Heidelberg, Heidelberg, Germany.
Quan Minh TranDengue Branch, Centers for Disease Control and Prevention, San Juan, Puerto Rico, United States of America.

Funding

The child health impacts of overlapping vector-borne diseases in KenyaR01AI102918 · NIAID · STANFORD UNIVERSITY · PI Angelle Desiree LaBeaud · 2013 to 2026
$7.7M
Leveraging environmental drivers to predict vector-borne disease transmissionR35GM133439 · NIGMS · STANFORD UNIVERSITY · PI Erin Mordecai · 2019 to 2026
$3.2M
Defining correlates of protection from dengue illness in a long-term cohort study of multigenerational house-holds in ThailandR01AI175941 · NIAID · UPSTATE MEDICAL UNIVERSITY · PI Kathryn B Anderson · 2023 to 2026
$2.7M
Modeling the influence of temperature on the evolution of vector-virus interactionsR01AI168097 · NIAID · WADSWORTH CENTER · PI Alexander Timothy Ciota · 2022 to 2026
$2.4M
NIAID NIH HHS R01 AI102918NIAID NIH HHS R01 AI168097NIAID NIH HHS R01 AI175941NIGMS NIH HHS R35 GM133439Wellcome TrustWorld Health Organization 001
6 · The paper itself

Abstract

Global risk maps are an important tool for assessing the global threat of mosquito and tick-transmitted arboviral diseases. Public health officials increasingly rely on risk maps to understand the drivers of transmission, forecast spread, identify gaps in surveillance, estimate disease burden, and target and evaluate the impact of interventions. Here, we describe how current approaches to mapping arboviral diseases have become unnecessarily siloed, ignoring the strengths and weaknesses of different data types and methods. This places limits on data and model output comparability, uncertainty estimation and generalisation that limit the answers they can provide to some of the most pressing questions in arbovirus control. We argue for a new generation of risk mapping models that jointly infer risk from multiple data types. We outline how this can be achieved conceptually and show how this new framework creates opportunities to better integrate epidemiological understanding and uncertainty quantification. We advocate for more co-development of risk maps among modellers and end-users to better enable risk maps to inform public health decisions. Prospective validation of risk maps for specific applications can inform further targeted data collection and subsequent model refinement in an iterative manner. If the expanding use of arbovirus risk maps for control is to continue, methods must develop and adapt to changing questions, interventions and data availability.

Indexed as

Arbovirus InfectionsAnimalsArbovirusesComputational BiologyForecastingGlobal HealthHumansRisk Assessment

Identifiers

PMID40184562
PMCPMC11970912

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.